Sarepta said on Monday that its late-stage study testing two gene-targeted therapies for Duchenne muscular dystrophy did not ...
A long-running confirmatory trial of two of Sarepta Therapeutics’ Duchenne muscular dystrophy drugs has missed its main goal.
Merck and Eisai's experimental combination treatment helped extend the time certain patients with advanced kidney cell cancer ...
The biotech’s phase 3 delivered the hoped-for second biomarker hit, reporting an 82% decline in serum creatine kinase after ...
Multivariate statistical inference encompasses methods that evaluate multiple outcomes or parameters jointly, allowing researchers to understand complex interdependencies within data. Permutation ...
From all my years in research and consulting, I think I’ve learned a thing or two about marketing worth sharing. Enduring fundamentals, mostly—yet often overlooked. So, over the course of my biweekly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback